CMS Bureau Francis Lefebvre advised the main director of Goëmar on the acquisition of the group by Arysta LifeScience Limited from BeCapital and Pechel Industries.
Goëmar is based in Saint-Malo, France, and is a global manufacturer and supplier of biostimulation, biocontrol and innovative nutrition for plants, including Physio Activator and natural defence technologies.
The director of Goëmar was advised in relation to this transaction by CMS Bureau Francis Lefebvre with Philippe Rosenpick (partner), Arnaud Hugot (partner), Alexandre Delhaye, Emmanuelle Brunel and Alexandre Morel for Corporate/M&A aspects and Lionel Lenczner (partner) for tax aspects.
BeCapital and Pechel Industries were advised by Willkie Farr & Gallagher LLP with Annette Peron (partner), Grégoire Finance (partner) and Virgine Sayag and STC Partners with Christian Couderc (founding partner) and Denis Fontaine-Besset (partner).
Arysta was advised by Freshfields Bruckhaus Deringer LLP with Jean-Claude Cotoni (partner), Sibylle Renard-Payen and Ferielle Habili.
For more information, please contact